Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
1404.00Today’s High
1474.4052W low
825.0052W High
1490.00Open Price
1405.00Prev. Close
1149.6000Volume
98044.00Value
141011783.00Fundamentals
Market Cap Cr
2820.50
Price to Earnings
-60.10
Price to Book Value
7.60
Dividend Yield
0.10
PE to Growth
0.20
Op Revenue TTM Cr
458.18
Net Profit TTM Cr
-46.93
Cash From Operating Activity Cr
10.22
Return on Equity %
-12.70
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
02 Jul, 2024
55.3
Week
57.2
Month
58.3
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1391.77
PIVOT
First Resistance
1433.33
Second Resistance
1465.57
Third Resistance
1507.13
First Support
1359.53
Second Support
1317.97
Third Support
1285.73
Relative Strength Index
72
Money Flow Index
79.95
MACD
48.72
MACD Signal
37.35
Average True Range
58.57
Average Directional Index
32.34
Rate of Change (21)
27.86
Rate of Change (125)
27.93
Commodity Channel Index
134
Williams %R
-8.5
BETA
1 Month
0.45
3 Month
0.66
1 Year
0.31
3 Year
0.1
PRICE CHANGE ANALYSIS
↑ 10.45%
1 Week
Low
High
1269.9
1474.4
↑ 31.25%
1 Month
Low
High
1031
1474.4
↑ 31.23%
3 Months
Low
High
1031
1474.4
↑ 29.17%
6 Months
Low
High
825.05
1474.4
↑ 8.31%
1 Year
Low
High
825.05
1490
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 155.78 | 51.69 | 111.74 | 144.55 | 129.54 | 120.96 | 203.73 | 186.97 | 278.78 | 175.31 | 103.47 | |
| Operating Expenses Qtr | 141.04 | 69.12 | 114.21 | 139.71 | 121.57 | 105.05 | 166.47 | 158.81 | 206.52 | 130.49 | 81.49 | |
| Operating Profit Qtr | 12.71 | -18.33 | -3.42 | 3.14 | 5.40 | 12.13 | 33.28 | 25.45 | 65.46 | 42.86 | 21.08 | |
| EBIDT Qtr Cr | 14.74 | -17.43 | -2.46 | 4.83 | 7.97 | 15.91 | 37.26 | 28.16 | 72.26 | 44.82 | 21.98 | |
| Depreciation Qtr | 9.02 | 8.72 | 9.17 | 9.40 | 7.77 | 8.81 | 8.18 | 8.94 | 10.66 | 9.07 | 8.17 | |
| Net Profit Qtr | -0.99 | -24.35 | -13.45 | -8.21 | -5.00 | 0.83 | 18.30 | 11.39 | 43.04 | 24.74 | 9.06 | |
| Basic EPS Qtr | -0.50 | -12.42 | -6.86 | -4.19 | -2.55 | 0.42 | 9.34 | 5.81 | 21.97 | 12.63 | 4.63 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 463.76 | 641.20 | 687.03 | 562.54 | 534.15 | |
| Operating Expenses Annual Cr | 464.08 | 551.90 | 522.48 | 443.37 | 437.02 | |
| Operating Profit Annual | -5.90 | 76.27 | 154.08 | 111.51 | 85.20 | |
| Operating Profit Margin Annual % | -1.27 | 11.89 | 22.43 | 19.82 | 15.95 | |
| Total Expenses Annual Cr | 525.64 | 606.35 | 565.99 | 473.87 | 472.88 | |
| EBIDT Annual Cr | -0.32 | 89.30 | 164.55 | 119.18 | 97.14 | |
| EBIDT Annual margin % | -0.07 | 13.93 | 23.95 | 21.19 | 18.19 | |
| Depreciation | 36.31 | 33.71 | 34.42 | 25.71 | 23.22 | |
| PAT Before ExtraOrdinary Items Annual Cr | -46.99 | 25.52 | 89.82 | 64.69 | 47.47 | |
| Net Profit Annual | -46.99 | 25.52 | 89.82 | 64.69 | 47.47 | |
| Basic EPS Annual | -23.96 | 13.02 | 45.85 | 33.05 | 24.27 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 368.68 | 418.79 | 395.98 | 308.70 | 246.44 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 208.22 | 33.73 | 9.75 | 46.23 | 6.78 | |
| Total Current Liabilities Annual Cr | 397.25 | 526.33 | 490.98 | 322.97 | 318.88 | |
| Total Capital Plus Liabilities Annual Cr | 974.15 | 978.85 | 896.71 | 677.90 | 572.10 | |
| Fixed Assets Annual | 550.82 | 444.95 | 362.71 | 328.38 | 217.79 | |
| Total Non Current Assets Annual | 576.67 | 480.75 | 378.90 | 347.47 | 240.41 | |
| Total Current Assets Annual | 397.48 | 498.09 | 517.81 | 330.43 | 331.69 | |
| Total Assets Annual | 974.15 | 978.85 | 896.71 | 677.90 | 572.10 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 256.13 | 215.22 | 233.72 | 209.82 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 10.13 | 74.32 | 23.41 | -8.06 | 168.56 | |
| Cash from Investing Activity Annual | -134.98 | -112.07 | -103.57 | -73.11 | -73.81 | |
| Cash from Financing Annual Activity | 124.85 | 37.66 | 80.37 | 81.23 | -94.64 | |
| Net Cash Flow Annual | - | -0.09 | 0.22 | 0.06 | 0.11 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 188.01 | 213.61 | 202.06 | 157.60 | 125.94 | |
| ROE Annual % | -12.74 | 6.09 | 22.68 | 20.95 | 19.26 | |
| ROCE Annual % | -6.34 | 12.28 | 32.07 | 26.33 | 29.18 | |
| Total Debt to Total Equity Annual | 1.34 | 0.81 | 0.71 | 0.61 | 0.40 | |
| EBDIT Annual Margin % | -0.06 | 14.21 | 24.32 | 21.47 | 18.60 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 155.80 | 51.70 | 111.77 | 144.56 | 129.55 | 120.97 | 203.73 | 186.98 | 278.79 | 175.31 | 103.47 | |
| Operating Expenses Qtr | 141.04 | 69.13 | 114.21 | 139.72 | 121.57 | 105.06 | 166.47 | 158.82 | 206.52 | 130.49 | 81.49 | |
| Operating Profit Qtr | 12.71 | -18.33 | -3.42 | 3.13 | 5.40 | 12.12 | 33.28 | 25.45 | 65.46 | 42.86 | 21.08 | |
| EBIDT Qtr Cr | 14.76 | -17.42 | -2.44 | 4.84 | 7.98 | 15.91 | 37.26 | 28.16 | 72.27 | 44.82 | 21.98 | |
| Depreciation Qtr | 9.01 | 8.70 | 9.16 | 9.39 | 7.76 | 8.80 | 8.17 | 8.93 | 10.64 | 9.06 | 8.15 | |
| Net Profit Qtr | -0.97 | -24.33 | -13.43 | -8.19 | -4.98 | 0.84 | 18.31 | 11.40 | 43.05 | 24.75 | 9.08 | |
| Basic EPS Qtr | -0.50 | -12.41 | -6.85 | -4.18 | -2.54 | 0.43 | 9.34 | 5.82 | 21.97 | 12.63 | 4.63 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 463.82 | 641.23 | 687.03 | 562.79 | 534.54 | |
| Operating Expenses Annual Cr | 464.09 | 551.91 | 522.49 | 443.32 | 437.43 | |
| Operating Profit Annual | -5.91 | 76.25 | 154.07 | 111.56 | 85.18 | |
| Operating Profit Margin Annual % | -1.27 | 11.89 | 22.43 | 19.82 | 15.93 | |
| Total Expenses Annual Cr | 525.57 | 606.28 | 565.91 | 473.72 | 473.19 | |
| EBIDT Annual Cr | -0.27 | 89.31 | 164.54 | 119.48 | 97.11 | |
| EBIDT Annual margin % | -0.06 | 13.93 | 23.95 | 21.23 | 18.17 | |
| Depreciation | 36.25 | 33.65 | 34.36 | 25.66 | 23.16 | |
| PAT Before ExtraOrdinary Items Annual Cr | -46.89 | 25.59 | 89.88 | 65.07 | 47.53 | |
| Net Profit Annual | -46.93 | 25.56 | 89.86 | 65.05 | 47.51 | |
| Basic EPS Annual | -23.93 | 13.04 | 45.85 | 33.21 | 24.27 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 369.29 | 419.36 | 396.50 | 309.18 | 246.57 | |
| Minority Interest Liability Annual Cr | 0.23 | 0.19 | 0.16 | 0.14 | 0.33 | |
| Total Non Current Liabilities Annual Cr | 208.25 | 33.66 | 9.51 | 45.99 | 6.46 | |
| Total Current Liabilities Annual Cr | 397.16 | 526.20 | 490.59 | 322.28 | 318.36 | |
| Total Capital Plus Liabilities Annual Cr | 974.93 | 979.41 | 896.76 | 677.59 | 571.72 | |
| Fixed Assets Annual | 551.00 | 445.08 | 362.77 | 328.39 | 217.73 | |
| Total Non Current Assets Annual | 576.44 | 480.56 | 381.08 | 347.16 | 239.97 | |
| Total Current Assets Annual | 398.49 | 498.85 | 515.68 | 330.43 | 331.75 | |
| Total Assets Annual | 974.93 | 979.41 | 896.76 | 677.59 | 571.72 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 256.17 | 239.82 | 233.75 | 274.87 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 10.22 | 74.66 | 23.60 | -8.16 | 168.44 | |
| Cash from Investing Activity Annual | -135.18 | -112.51 | -103.87 | -73.11 | -73.81 | |
| Cash from Financing Annual Activity | 124.96 | 37.77 | 80.48 | 81.34 | -94.53 | |
| Net Cash Flow Annual | - | -0.08 | 0.22 | 0.06 | 0.10 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 188.44 | 214.00 | 202.40 | 157.91 | 126.17 | |
| ROE Annual % | -12.70 | 6.09 | 22.66 | 21.03 | 19.26 | |
| ROCE Annual % | -6.32 | 12.28 | 32.05 | 26.40 | 29.18 | |
| Total Debt to Total Equity Annual | 1.34 | 0.81 | 0.70 | 0.60 | 0.40 | |
| EBDIT Annual Margin % | -0.05 | 14.21 | 24.31 | 21.53 | 18.58 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| ICICI PRUDENTIAL MULTICAP FUND | 5.3 | 74803185 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| ASHOK VISHWANATH HIREMATH | 1.99 | 74803179 | 0 | 0 |
| GODREJ AGROVET LIMITED | 64.76 | 74803182 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| ICICI PRUDENTIAL MULTICAP FUND | 5.3 | 74803185 |
| NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMALL CAP FUND | 2.39 | 74803186 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| SHREANS DAGA | 1.9 | 74803199 |
| KAUSHIK DAGA | 1.67 | 74803200 |
| HUF | 1.1 | 74803192 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jul 21, 2023 | 1.5 | FINAL | - | Equity Share |
| Jul 19, 2022 | 1.5 | FINAL | - | Equity Share |
| Jul 22, 2021 | 1.5 | FINAL | - | Equity Share |
| Jul 16, 2020 | 1.5 | FINAL | - | Equity Share |
| Jul 18, 2019 | 1.5 | FINAL | - | Equity Share |
| Jul 19, 2018 | 1.5 | FINAL | - | Equity Share |
| Jul 17, 2017 | 1.5 | FINAL | - | Equity Share |
| Sep 15, 2015 | 1.25 | FINAL | - | Equity Share |
| Sep 15, 2014 | 1 | FINAL | - | Equity Share |
| Sep 02, 2013 | 0.75 | FINAL | - | Equity Share |
| Sep 13, 2012 | 0.5 | FINAL | - | Equity Share |
| Sep 15, 2011 | 0.5 | FINAL | - | Equity Share |
| Aug 12, 2010 | 1 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 02, 2024 | Audited Results | - |
| Jan 25, 2024 | Quarterly Results | - |
| Oct 27, 2023 | Quarterly Results & Others | - |
| Jul 27, 2023 | Quarterly Results | - |
| May 02, 2023 | Audited Results & Final Dividend | - |
| Jan 30, 2023 | Quarterly Results & Others | Inter alia, the Board may also consider and approve issuance of Debentures or debt securities upto such limit as may be deemed appropriate and approved by the Board. |
| Oct 28, 2022 | Quarterly Results | - |
| Jul 25, 2022 | Quarterly Results | - |
| May 02, 2022 | Audited Results & Final Dividend | - |
| Jan 25, 2022 | Quarterly Results | - |
| Oct 27, 2021 | Quarterly Results | - |
| Jul 28, 2021 | Quarterly Results | - |
| Apr 30, 2021 | Audited Results & Final Dividend | - |
| Jan 25, 2021 | Quarterly Results | - |
| Oct 29, 2020 | Quarterly Results | - |
| Jul 22, 2020 | Quarterly Results | - |
| May 05, 2020 | Audited Results & Final Dividend | - |
| Jan 30, 2020 | Quarterly Results | - |
| Oct 25, 2019 | Quarterly Results | - |
| Jul 26, 2019 | Quarterly Results | - |
| Apr 30, 2019 | Audited Results & Final Dividend | - |
| Jan 25, 2019 | Quarterly Results | - |
| Oct 26, 2018 | Quarterly Results | - |
| Sep 14, 2018 | Amalgamation | inter alia, to consider and approve Scheme of Amalgamation of the Company with Godrej Agrovet Limited (Holding Company). |
| Aug 01, 2018 | Quarterly Results | - |
| May 02, 2018 | Audited Results & Final Dividend | - |
| Jan 31, 2018 | Quarterly Results | - |
| Oct 25, 2017 | Quarterly Results | - |
| Jul 28, 2017 | Quarterly Results | - |
| May 04, 2017 | Audited Results & Final Dividend | - |
| Mar 25, 2017 | Others | Allotted 9,000 (Nine Thousand) Equity Shares of Face Value Rs.10/- each to the employees of the Company upon exercise of 9,000 (Nine Thousand) Options granted to them, at an exercise price of Rs.34/- |
| Jan 25, 2017 | Quarterly Results | - |
| Oct 27, 2016 | Quarterly Results | - |
| Jul 26, 2016 | Quarterly Results | Allotted 21,200 (Twenty One Thousand Two Hundred) Equity Shares of Face Value Rs.10/- each to the employees of the Company on exercise of Options granted to them, at an exercise price of Rs. 34/-. |
| May 04, 2016 | Audited Results | - |
| Jan 29, 2016 | Quarterly Results | 1. Appointment of Mr. Vijay Kashinath Khot as an Additional Independent Director of the Company with immediate effect; 2. Appointment of Dr. Brahma Nand Vyas as an Additional Independent Director. |
| Nov 06, 2015 | Quarterly Results | 1. Appointment Mr. N. B. Godrej as the Chairman of the Company. 2. Appointment of Mr. S. Varadaraj as an Additional Director of the Company. |
| Oct 12, 2015 | Others | Appointment of Mr. N. B. Godrej as Additional Director of the Company with immediate effect. |
| Jul 25, 2015 | Quarterly Results | - |
| May 16, 2015 | Audited Results & Dividend | - |
| Mar 05, 2015 | Re-appointment of Managing Director | Re-appointment of Mr. Janak Rawal as Whole Time Director subject to the approval of members. |
| Jan 31, 2015 | Qtrly Results & Allotment of Equity Shares | To consider allotment of 9,25,925 Equity Shares of Rs. 10/- each fully paid-up at Rs. 108/- per share (including a premium of Rs. 98/- per share) on preferential basis. |
| Dec 19, 2014 | To Consider Allotment of Equity Shares | To consider and approve the issue and allotment of Equity shares on Preferential basis of Rs.10,00,00,000/- (Rupees Ten Crores Only) including premium thereon, |
| Oct 18, 2014 | Quarterly Results | - |
| Aug 09, 2014 | Quarterly Results & Others | To alter Memorandum and Articles of Association of Company to give effect to item to increase the Authorised Capital of the Company. |
| May 30, 2014 | Audited Results & Dividend, Others | 1. Increase in Authorised Capital . 2. To alter Memorandum and Articles of Association of Company to give effect to item no. 3 & 4 above. Revised from 14/05/2014. |
| Jan 24, 2014 | Quarterly Results | - |
| Oct 23, 2013 | Quarterly Results | - |
| Sep 19, 2013 | Allotment of Equity Shares | For approving the Allotment of Equity Shares pursuant to the Conversion of Preferential Warrants convertible into Equity Shares. |
| Aug 12, 2013 | Quarterly Results | - |
| May 24, 2013 | Audited Results & Dividend | - |
| Feb 14, 2013 | Quarterly Results | - |
| Jan 04, 2013 | Conversion of Preferential Warrants | To Consider the Allotment of Equity Shares pursuant to the Conversion of Preferential Warrants convertible into Equity Shares. |
| Nov 12, 2012 | Quarterly Results | - |
| Aug 09, 2012 | Quarterly Results | - |
| May 28, 2012 | Audited Results, Dividend & Others | To appoint Non-Executive & Independent Director. |
| Feb 29, 2012 | Increase in Authorised Capital & Others | To increase Authorized Capital of the Company from Rs. 17,00,00,OOO/- to Rs. 20,00,00,OOO/- & to issuance of 16,00,000 Convertible Warrants into Equity Shares on preferential basis. |
| Feb 14, 2012 | Quarterly Results | - |
| Jan 04, 2012 | Appointment of Whole Time Director | To consider the followings: 1. Appointment of Mr. Janak Rawal as Whole Time Director, subject to the approval of members. 2. Re-appointment of Mr. Ashok V Hiremath as Chairman & Managing Director. |
| Nov 12, 2011 | Quarterly Results | - |
| Aug 10, 2011 | Quarterly Results | - |
| May 27, 2011 | Audited Results & Dividend | - |
| Feb 05, 2011 | Quarterly Results | - |
| Nov 10, 2010 | Quarterly Results | - |
| Aug 05, 2010 | Quarterly Results | - |
| May 24, 2010 | Audited Results & Dividend | - |
| Jan 28, 2010 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
28 Jun 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Closure of Trading Window
Kindly find enclosed the intimation of Closure of the Trading Window for the Quarter ending June 30, 2024.
28 Jun 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Kindly find enclosed the Newspaper Advertisement of 30th AGM of the Company which is going to be conducted through VC / OAVM.
26 Jun 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Update On Family Settlement Agreement Dated April 30, 2024 Under Regulations 30 And 30(7) Of SEBI (LODR) Regulations, 2015.
Further to the intimations submitted to the Stock Exchanges on April 30, 2024 and June 19, 2024, please find attached and update on Family Settlement Agreement which is Self - explanatory in nature.
26 Jun 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Update On Family Settlement Agreement Dated April 30, 2024 Under Regulations 30 And 30(7) Of SEBI (LODR) Regulations, 2015
Further to the Intimations submitted to the Stock Exchanges on April 30, 2024 and June 19, 2024, please find attached an update on the Family Settlement Agreement which is self- explanatory in nature.
24 Jun 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Change In Senior Management Personnel Of The Company
Kindly find enclosed the Intimation of Change in Senior Management Personnel of the Company.
19 Jun 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Update On Approval Received By Godrej Family From The Competition Commission Of India For The Family Re-Alignment.
Further to the intimation given to the Stock Exchanges on April 30, 2024 under Regulation 30 read with Regulation 30A in connection with the execution of the Family Settlement Agreement and a Brand & Non-compete Agreement between the Members of Godrej Family, we have been informed by the Godrej Family members that the Competition Commission of India has approved the proposed re-alignment on June 18, 2024.
13 Jun 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Credit Rating
Kindly find enclosed the intimation regarding the reaffirmed credit rating.
13 Jun 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Kindly find enclosed the intimation under Regulation 30.
29 May 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirement) Regulations, 2015.
Kindly find enclosed the intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 with regard to the communication received from the Maharashtra Pollution Control Board (MPCB) dated May 28, 2024.
27 May 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Kindly find enclosed the Annual Secretarial Compliance Report of the Company for the Financial Year ended March 31, 2024.
